Roivant Sciences Ltd. Warrant
ROIVW
ROIVW was delisted on the 1st of September, 2023.
28 hedge funds and large institutions have $48.9M invested in Roivant Sciences Ltd. Warrant in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
218% more capital invested
Capital invested by funds: $15.4M → $48.9M (+$33.5M)
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 30 → 28 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CSS LLC
Chicago,
Illinois
|
+$576K |
| 2 |
TSC
Two Seas Capital
Rye,
New York
|
+$567K |
| 3 |
D.E. Shaw & Co
New York
|
+$513K |
| 4 |
ICM
Ionic Capital Management
New York
|
+$503K |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$449K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Centiva Capital
New York
|
-$788K |
| 2 |
Walleye Capital
New York
|
-$115K |
| 3 |
KC
Kepos Capital
New York
|
-$93K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$59K |
| 5 |
CC
Clearline Capital
New York
|
-$33.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Walleye Capital
New York
| $32.3K | -$115K | -104,700 | -86% |
|
27
Walleye Trading
New York
| $21.5K | – | – | – |
|
28
UBS Group
Zurich,
Switzerland
| $2.22K | -$6.59K | -6,023 | -84% |
|
|
CC
29
Centiva Capital
New York
| – | -$788K | -2,020,940 | Closed |
|
|
KC
30
Kepos Capital
New York
| – | -$93K | -237,500 | Closed |
|
|
31
Balyasny Asset Management
Chicago,
Illinois
| – | -$59K | -150,000 | Closed |
|
|
ECU
32
Eisler Capital (UK)
London,
United Kingdom
| – | -$18K | -45,221 | Closed |
|
|
WAM
33
Wolverine Asset Management
Chicago,
Illinois
| – | -$2K | -6,197 | Closed |
|
ROIVW Hedge Fund Activity: Q4 2022 in Review
28 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences Ltd. Warrant (ROIVW) for Q4 2022, worth a combined $48.9M — up 218% from $15.4M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ROIVW and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 7 added.
The largest buyer was CSS LLC, opening a new position worth an estimated $576K. The largest seller was Centiva Capital, exiting entirely with an estimated $788K sold.
- 28 institutional investors held Roivant Sciences Ltd. Warrant (ROIVW) as of Q4 2022, down from 30 in Q3 2022.
- Funds reported $48.9M of Roivant Sciences Ltd. Warrant stock for Q4 2022, up 218% quarter-over-quarter.
- 4 funds opened new Roivant Sciences Ltd. Warrant positions in Q4 2022 and 5 closed out, a net change of -1 holder.
- The largest Roivant Sciences Ltd. Warrant buyer in Q4 2022 was CSS LLC, an estimated $576K added.
- The largest Roivant Sciences Ltd. Warrant seller in Q4 2022 was Centiva Capital, an estimated $788K sold.
Based on aggregated 13F filings for Q4 2022.